Taiwanese (TAIEX) Growth Pharmaceuticals & Biotech Stocks

UPDATED Apr 23, 2024

Discover Taiwanese Pharmaceuticals & Biotech Growth Stocks that are on the TAIEX. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.

121 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6589

EirGenix
NT$78.20-1.1%-26.2%NT$23.9bNT$132.50PS23.4xE143.6%n/a

6446

PharmaEssentia
NT$287.50-5.3%-22.1%NT$95.4bNT$417.25PS18.7xE109.0%n/a

6535

Lumosa Therapeutics
NT$168.00-9.9%304.3%NT$27.7bNT$2.28PS487xE107.6%n/a

4147

TaiMed Biologics
NT$82.80-5.8%-26.1%NT$20.9bNT$133.69PS42.6xE97.0%n/a

4743

Oneness Biotech
NT$155.00-2.5%-27.1%NT$70.3bNT$262.00PS810.1xE46.9%0.06%

6472

Bora Pharmaceuticals
NT$751.00-2.6%38.6%NT$76.0bNT$865.00PE25.1xE22.9%1.6%

1795

Lotus Pharmaceutical
NT$320.50-4.0%25.9%NT$84.8bNT$390.20PE20.6xE20.5%1.1%

4105

TTY Biopharm
NT$76.50-0.5%1.3%NT$19.0bNT$86.50PE16.9xE18.7%4.6%

8279

Syngen BiotechLtd
NT$153.001.3%-13.6%NT$4.1bNT$170.00PE15.1xE8.1%3.3%

6566

Chuang Yi Biotech
NT$5.200%-65.3%NT$176.5mn/aPB1.3xn/an/a

7607

DuoGenic StemCells
NT$32.001.3%n/aNT$977.7mn/an/an/an/a

6634

Sinew Pharma
NT$57.90-7.9%-31.6%NT$4.1bn/aPB3.1xn/an/a

6949

PELL Bio-Med Technology
NT$140.0018.6%n/aNT$7.6bn/aPS418.8xn/an/a

6939

TFBS Bioscience
NT$41.50-0.5%n/aNT$1.4bn/an/an/an/a

6936

Vetnostrum Animal Health
NT$36.40-0.3%0.3%NT$2.4bn/an/an/an/a

6785

Alar Pharmaceuticals
NT$301.50-1.1%83.8%NT$20.1bn/aPE52.6xn/a0.5%

1295

Synbio Tech
NT$73.00-5.2%n/aNT$2.2bn/an/an/an/a

6712

Ever Supreme Bio Technology
NT$204.500%2.7%NT$15.0bn/aPE27.8xn/a1.7%

4195

Genomics BioSci & Tech.Ltd
NT$18.502.2%-7.0%NT$1.3bn/aPS3.4xn/a0.5%

4127

Tien Liang BioTech
NT$30.35-18.6%99.7%NT$1.4bn/aPE78.3xn/a0%

6917

Andros PharmaceuticalsLtd
NT$21.55-0.5%-39.9%NT$749.3mn/an/an/an/a

1789

ScinoPharm Taiwan
NT$28.003.9%3.1%NT$22.1bNT$26.00PE77.1xn/a1.1%

6549

TaiwanJ Pharmaceuticals
NT$12.05-4.0%-61.1%NT$905.2mn/aPS39.8xn/an/a

4111

Chi Sheng Pharma & Biotech
NT$25.80-1.5%-15.5%NT$1.5bn/aPE21.4xn/a3.9%
Page 1 of 6
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.